Silk Road Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	20.21	55.51	110.46	69.78	39.49	25.3	33.84
Short-Term Investments	161.26	158.32	0	78.02	51.51	0	0
Cash & Cash Equivalents	181.47	213.83	110.46	147.79	91	25.3	33.84
Cash Growth	-15.13%	93.58%	-25.26%	62.41%	259.68%	-25.24%	-
Receivables	23.57	18.01	11.83	9.07	8.6	6.38	5.22
Inventory	29.88	19.29	17.85	9.99	10.32	5.74	3.25
Other Current Assets	5.91	3.77	3.18	6.48	2.57	1.1	-0.23
Total Current Assets	240.84	254.9	143.33	173.33	112.49	38.52	42.07
Property, Plant & Equipment	8.11	9.37	7.7	2.84	2.73	2.88	0.49
Long-Term Investments	9.46	0	0	0	18.22	0	0
Other Long-Term Assets	6.9	5.42	5.6	3.14	3.95	1.34	0.53
Total Long-Term Assets	24.47	14.79	13.3	5.99	24.91	4.22	1.01
Total Assets	265.31	269.69	156.63	179.31	137.4	42.74	43.09
Accounts Payable	5.68	2.52	2.38	2.6	1.9	1.25	1.55
Current Debt	0	0	3.91	0	0	0	0
Other Current Liabilities	24.61	21.97	19.8	16.96	15.03	9.45	3.11
Total Current Liabilities	30.28	24.49	26.09	19.56	16.93	10.7	4.66
Long-Term Debt	75.63	74.6	44.79	48.53	44.88	44.2	27.59
Other Long-Term Liabilities	8.25	6.73	6.51	3.73	3.7	17.16	4.19
Total Long-Term Liabilities	83.88	81.32	51.3	52.26	48.58	61.36	31.77
Total Liabilities	114.16	105.81	77.39	71.81	65.51	72.06	36.43
Total Debt	75.63	74.6	48.69	48.53	44.88	44.2	27.59
Debt Growth	1.38%	53.20%	0.33%	8.14%	1.53%	60.21%	-
Retained Earnings	-399.46	-343.71	-288.7	-238.89	-191.53	-139.11	-101.56
Comprehensive Income	0.07	-0.17	0	0.04	0	0	0
Shareholders' Equity	151.15	163.88	79.24	107.5	71.89	-134.55	-98.58
Net Cash / Debt	105.85	139.23	61.77	99.26	46.12	-18.9	6.25
Net Cash / Debt Growth	-23.98%	125.40%	-37.77%	115.22%	-	-	-
Net Cash Per Share	2.73	3.89	1.78	3.01	2.01	-19.67	14.40
Working Capital	210.55	230.41	117.24	153.77	95.56	27.82	37.42
Book Value Per Share	3.90	4.58	2.29	3.26	3.13	-140.03	-227.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).